Endothelin receptor regulation by endothelin synthesis in vascular smooth muscle cells: effects of dexamethasone and phosphoramidon. 1993

P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
Institut Henri Beaufour, Les Ulis, France.

One of the major biological effects of the endothelium-derived peptide endothelin-1 (ET-1) is its receptor-mediated constrictive action on vascular smooth muscle. In this study, we have examined the effects on the ET-1 pathway of 18 h exposure at 37 degrees C of cultured rat aortic smooth muscle cells to dexamethasone (DEX) and phosphoramidon. ET-1 synthesis was evaluated by radioimmunoassay, ET-1 binding characteristics were determined with [125I]iodo-ET-1, and ET-1-induced intracellular calcium mobilization was measured using fura-2-loaded cells. DEX (100 nM) led to a 2- to 3-fold-increase of ET-1 production, it down-regulated ET-1 receptors and reduced ET-1-stimulated calcium mobilization by 70%. In contrast, phosphoramidon (100 microM) inhibited ET-1 production by 60%, up-regulated ET-1 receptors and potentiated ET-1-induced calcium mobilization by 75%. These results indicate that the regulatory effects of DEX and phosphoramidon on ET-1 receptors are mediated via ET-1 production by the cells. This suggests an autocrine control of ET-1 receptors by endogenous ET-1 synthesis in vascular smooth muscle cells.

UI MeSH Term Description Entries
D007425 Intracellular Membranes Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES. Membranes, Intracellular,Intracellular Membrane,Membrane, Intracellular
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005246 Feedback A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system. Feedbacks
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived
D017466 Receptors, Endothelin Cell surface proteins that bind ENDOTHELINS with high affinity and trigger intracellular changes which influence the behavior of cells. Endothelin Receptors,Receptors, Endothelium-Derived Vasoconstrictor Factor,Endothelin Receptor,Endothelium Derived Vasoconstrictor Factor Receptors,Receptors, Endothelins,Receptor, Endothelin,Receptors, Endothelium Derived Vasoconstrictor Factor

Related Publications

P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
January 1995, Journal of cardiovascular pharmacology,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
January 1993, Life sciences,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
October 2009, Regulatory peptides,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
October 1996, Regulatory peptides,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
November 1991, FEBS letters,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
August 1992, Journal of cardiovascular pharmacology,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
January 1991, Journal of cardiovascular pharmacology,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
March 1991, The American journal of physiology,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
September 1992, The Journal of biological chemistry,
P Roubert, and I Viossat, and M O Lonchampt, and M Chapelat, and J Schulz, and P Plas, and V Gillard-Roubert, and P E Chabrier, and P Braquet
February 1989, Biochemical and biophysical research communications,
Copied contents to your clipboard!